- Home
- LSTA
as 06-26-2025 4:00pm EST
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
| Founded: | 1980 | Country: | United States |
| Employees: | N/A | City: | BASKING RIDGE |
| Market Cap: | 20.9M | IPO Year: | N/A |
| Target Price: | $15.00 | AVG Volume (30 days): | 9.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.30 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.87 - $4.20 | Next Earning Date: | 08-11-2025 |
| Revenue: | $1,000,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Lisata Therapeutics Inc. News
LSTA Breaking Stock News: Dive into LSTA Ticker-Specific Updates for Smart Investing
GlobeNewswire
a day ago
Positive Preliminary Cohort B Results from the AGITG-led ASCEND Trial to be Presented at ESMO GI Evaluating Lisata’s Certepetide in Combination with Standard-of-Care Chemotherapy in Metastatic Pancreatic Cancer
Pharmaceutical Technology
9 days ago
Lisata collaborates with GATC Health on drug development
GlobeNewswire
10 days ago
Lisata Therapeutics and GATC Health Expand Relationship to Advance AI-Driven Drug Discovery and Development
GlobeNewswire
16 days ago
Lisata Therapeutics to Present at the 2025 BIO International Convention
GuruFocus.com
2 months ago
Lisata Therapeutics Inc (LSTA) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Market ...
GlobeNewswire
2 months ago
Lisata Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
2 months ago
Lisata Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update on Thursday, May 8, 2025
Simply Wall St.
2 months ago
Will Lisata Therapeutics (NASDAQ:LSTA) Spend Its Cash Wisely?
Compare LSTA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LSTA Lisata Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.